Investor desk
Investors should track partnership announcements and pipeline signals from JPM.
← Back to Events
Tier 1 Global Networking: High GENERAL CONCLUDED
JPM — 2026 — The Westin St. Francis, San Francisco, USA
Annual gathering for pharmaceutical and biotech executives, investors, and business development leaders across the healthcare industry.
5,000+ Attendees
Presentation data updated Apr 18, 2026, 2:50 PM UTC
Why This Event Matters
Annual gathering for pharmaceutical and biotech executives, investors, and business development leaders across the healthcare industry.
Industry impact
Annual gathering for pharmaceutical and biotech executives, investors, and business development leaders across the healthcare industry..
Market implications
Expect signals on pricing, formulary strategy, and partnership economics in US markets.
Regulatory implications
FDA and CMS policy on evidence generation and real-world data often surface at leadership forums.
Investor implications
Investors should track partnership announcements and pipeline signals from JPM.
Competitive implications
Competitive positioning among general players is a core theme — compare with prior editions.
Event Significance
Tier-1 industry catalyst
36 /100 composite
JPM is a targeted general forum where specialty pipeline readouts and BD conversations drive near-term positioning decisions. Primary driver: speaker calibre and KOL density.
- Speaker quality 20/20
Plenary and late-breaker slots attract global KOLs — high signal for clinical and regulatory teams.
- Company participation 0/20
Smaller exhibitor set — focus on disclosed presenters rather than floor traffic.
- Historical influence 10/20
Some historical catalysts; compare readouts against last cycle.
- Media coverage 6/20
Niche coverage — subscribe for direct abstract alerts.
- Pipeline relevance 0/20
Early science or services-focused — lower near-term PDUFA linkage.
Key Takeaways
Key Themes
generalJ.P. MorganPipeline announcements
Key Markets
US Americas
Key Opportunities
Partnership dealsLicensing discussionsVendor selection
Timeline & Milestones
- Pre-event intelligence Complete
Abstract discovery in progress; monitor Key Data tab.
- Conference opens Jan 12, 2026 Complete
Live readouts, late-breakers, and partnership announcements.
- Live coverage window Complete
Nova editorial monitors confirmed data releases.
- Conference closes Jan 15, 2026 Complete
Post-event recap, competitive takeaways, and trial updates.
BD teams Investors & analysts Regulatory leaders
Executive Summary
C-level briefAnnual gathering for pharmaceutical and biotech executives, investors, and business development leaders across the healthcare industry.
Primary audience: BD teams · Investors & analysts · Regulatory leaders
Analyst Watch
Regulatory affairs
FDA and CMS policy on evidence generation and real-world data often surface at leadership forums.
Competitive intelligence
Competitive positioning among general players is a core theme — compare with prior editions.
Competitive Landscape
Company map →Competitive positioning among general players is a core theme — compare with prior editions.
Coverage & Analysis
No coverage articles yet. Check back closer to the event.
Related News & Research
Research hub →Event Intelligence Summary
Standalone summaries for JPM — optimized for research and AI retrieval.
Executive Summary
Annual gathering for pharmaceutical and biotech executives, investors, and business development leaders across the healthcare industry.
Analyst View
Annual gathering for pharmaceutical and biotech executives, investors, and business development leaders across the healthcare industry..
Investor View
Investors should track partnership announcements and pipeline signals from JPM.
BD View
BD teams should prioritize partnership and licensing conversations at JPM.
Key Facts
- Event
- JPM
- Focus
- general
- Region
- US Americas
- Attendance
- 5,000+
- Location
- San Francisco, USA
Ask Nova AI
AI-assisted answers grounded in NovaPharmaNews intelligence
Answers use retrieved site intelligence plus AI synthesis. Verify critical decisions with primary sources.
Frequently Asked Questions
What is JPM?
JPM is a general industry conference for executives, clinical leaders, and investors.
Who attends JPM?
Typical attendees include pharma executives, BD teams, investors, and regulatory professionals focused on general.
Why is JPM important?
JPM influences partnership timing and policy debates affecting general markets for the next 12–18 months.
Where is JPM held?
JPM is held in San Francisco, USA.
What should investors watch at JPM?
Track partnership announcements, pipeline readouts, and management commentary on general catalysts.
What BD opportunities exist at JPM?
BD teams use JPM for licensing, co-development, and vendor selection across general.
How does JPM compare with other pharma conferences?
JPM is a tier-1 global congress for general — compare with peer events in the same vertical.
How do I get NovaPharmaNews coverage of JPM?
Subscribe to event alerts on this page for pre-event briefs, live coverage, and post-event analysis.